117 related articles for article (PubMed ID: 2546793)
1. Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines.
Ullman B; Carrero-Valenzuela E; Coons T
Exp Parasitol; 1989 Aug; 69(2):157-63. PubMed ID: 2546793
[TBL] [Abstract][Full Text] [Related]
2. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
Ephros M; Waldman E; Zilberstein D
Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
[TBL] [Abstract][Full Text] [Related]
3. Biochemistry of Pentostam resistant Leishmania.
Berman JD; Edwards N; King M; Grogl M
Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
[TBL] [Abstract][Full Text] [Related]
4. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
Grögl M; Oduola AM; Cordero LD; Kyle DE
Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
[TBL] [Abstract][Full Text] [Related]
5. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
Martinez S; Looker DL; Berens RL; Marr JJ
Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
7. Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing.
Ibrahim ME; Hag-Ali M; el-Hassan AM; Theander TG; Kharazmi A
Parasitol Res; 1994; 80(7):569-74. PubMed ID: 7855121
[TBL] [Abstract][Full Text] [Related]
8. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).
Berman JD; Grogl M
Exp Parasitol; 1988 Oct; 67(1):96-103. PubMed ID: 2844580
[TBL] [Abstract][Full Text] [Related]
9. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil.
Neal RA; van Bueren J; McCoy NG; Iwobi M
Trans R Soc Trop Med Hyg; 1989; 83(2):197-8. PubMed ID: 2558433
[TBL] [Abstract][Full Text] [Related]
11. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
[TBL] [Abstract][Full Text] [Related]
12. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
13. Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani.
Chakraborty AK; Majumder HK
Biochem Biophys Res Commun; 1988 Apr; 152(2):605-11. PubMed ID: 2835038
[TBL] [Abstract][Full Text] [Related]
14. Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.
Murray HW; Berman JD; Wright SD
J Infect Dis; 1988 May; 157(5):973-8. PubMed ID: 2834469
[TBL] [Abstract][Full Text] [Related]
15. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Sereno D; Cavaleyra M; Zemzoumi K; Maquaire S; Ouaissi A; Lemesre JL
Antimicrob Agents Chemother; 1998 Dec; 42(12):3097-102. PubMed ID: 9835497
[TBL] [Abstract][Full Text] [Related]
16. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
Looker DL; Martinez S; Horton JM; Marr JJ
J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
[TBL] [Abstract][Full Text] [Related]
17. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
[TBL] [Abstract][Full Text] [Related]
19. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES
Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217
[TBL] [Abstract][Full Text] [Related]
20. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.
Haimeur A; Ouellette M
Antimicrob Agents Chemother; 1998 Jul; 42(7):1689-94. PubMed ID: 9661005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
